domingo, 14 de abril de 2019

Value-based agreements could disrupt how we pay for drugs - STAT

Value-based agreements could disrupt how we pay for drugs - STAT

First Opinion

Value-based agreements could disrupt how we pay for new therapies

By STEVE BROZAK


WIN MCNAMEE/GETTY IMAGES
Paying for therapies based on the value they provide could revolutionize how medicines are priced and reimbursed in the U.S.

No hay comentarios: